05/06/2015 - 01:09
SILVER SPRING, MD. – The majority of a Food and Drug Administration advisory panel has supported the approval of flibanserin, an oral, centrally-acting, non-hormonal drug taken once a day for...
Field of Interest: Pulmonology
Categories:
News Feed: Internal Medicine News - Pulmonology